Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
66.6M
-
Shares change
-
+310K
-
Total reported value, excl. options
-
$3.87B
-
Value change
-
+$17.9M
-
Number of buys
-
92
-
Number of sells
-
-96
-
Price
-
$58.08
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2015
226 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2015.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.6M shares
of 71.9M outstanding shares and own 92.54% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (6.51M shares), VANGUARD GROUP INC (5.66M shares), Neuberger Berman Group LLC (5.33M shares), FRANKLIN RESOURCES INC (4.34M shares), BlackRock Fund Advisors (4.24M shares), BAMCO INC /NY/ (2.54M shares), STATE STREET CORP (2.41M shares), KALMAR INVESTMENTS INC /DE/ (2.05M shares), BlackRock Institutional Trust Company, N.A. (1.65M shares), and ROYAL BANK OF CANADA (1.58M shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.